Eastwood Bio-Medical Canada Inc. (EBM.V)
CAD 0.65
(-7.14%)
CAD 0.65
(-7.14%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 867.93 Thousand CAD | -33.22% |
| 2022 | 1.29 Million CAD | 32.49% |
| 2021 | 981.05 Thousand CAD | 36.57% |
| 2020 | 718.33 Thousand CAD | -44.44% |
| 2019 | 1.29 Million CAD | 73.78% |
| 2018 | 743.97 Thousand CAD | 55.08% |
| 2017 | 479.72 Thousand CAD | 3.4% |
| 2016 | 463.93 Thousand CAD | -60.89% |
| 2015 | 1.18 Million CAD | 157.0% |
| 2014 | 461.51 Thousand CAD | -20.47% |
| 2013 | 580.32 Thousand CAD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 201 Thousand CAD | 55.72% |
| 2024 Q2 | 135.19 Thousand CAD | -32.74% |
| 2024 Q3 | 188.26 Thousand CAD | 39.25% |
| 2023 Q3 | 187.01 Thousand CAD | -14.86% |
| 2023 FY | 867.93 Thousand CAD | -33.22% |
| 2023 Q1 | 332.18 Thousand CAD | -12.79% |
| 2023 Q2 | 219.65 Thousand CAD | -33.88% |
| 2023 Q4 | 129.08 Thousand CAD | -30.98% |
| 2022 Q3 | 285.22 Thousand CAD | -5.74% |
| 2022 FY | 1.29 Million CAD | 32.49% |
| 2022 Q4 | 380.91 Thousand CAD | 33.55% |
| 2022 Q2 | 302.61 Thousand CAD | -8.58% |
| 2022 Q1 | 331.01 Thousand CAD | 22.29% |
| 2021 FY | 981.05 Thousand CAD | 36.57% |
| 2021 Q3 | 225.24 Thousand CAD | -21.21% |
| 2021 Q4 | 270.68 Thousand CAD | 20.18% |
| 2021 Q2 | 285.87 Thousand CAD | 43.48% |
| 2021 Q1 | 199.24 Thousand CAD | -1.87% |
| 2020 Q4 | 203.03 Thousand CAD | 9.84% |
| 2020 Q1 | 136.78 Thousand CAD | -51.66% |
| 2020 Q2 | 193.66 Thousand CAD | 41.58% |
| 2020 Q3 | 184.85 Thousand CAD | -4.55% |
| 2020 FY | 718.33 Thousand CAD | -44.44% |
| 2019 Q1 | 480.05 Thousand CAD | 15.92% |
| 2019 Q2 | 318.64 Thousand CAD | -33.62% |
| 2019 Q3 | 211.25 Thousand CAD | -33.7% |
| 2019 Q4 | 282.95 Thousand CAD | 33.94% |
| 2019 FY | 1.29 Million CAD | 73.78% |
| 2018 Q2 | 71.73 Thousand CAD | -23.21% |
| 2018 FY | 743.97 Thousand CAD | 55.08% |
| 2018 Q4 | 414.13 Thousand CAD | 151.47% |
| 2018 Q3 | 164.68 Thousand CAD | 129.59% |
| 2018 Q1 | 93.41 Thousand CAD | 5.79% |
| 2017 Q1 | 108.82 Thousand CAD | 12.07% |
| 2017 Q2 | 156.27 Thousand CAD | 43.6% |
| 2017 Q4 | 88.3 Thousand CAD | -30.1% |
| 2017 FY | 479.72 Thousand CAD | 3.4% |
| 2017 Q3 | 126.32 Thousand CAD | -19.16% |
| 2016 Q1 | 182.26 Thousand CAD | -33.78% |
| 2016 Q2 | 102.42 Thousand CAD | -43.8% |
| 2016 Q3 | 82.13 Thousand CAD | -19.81% |
| 2016 FY | 463.93 Thousand CAD | -60.89% |
| 2016 Q4 | 97.1 Thousand CAD | 18.22% |
| 2015 Q1 | 145.67 Thousand CAD | -1.65% |
| 2015 Q3 | 363.27 Thousand CAD | -9.61% |
| 2015 Q4 | 275.23 Thousand CAD | -24.24% |
| 2015 Q2 | 401.91 Thousand CAD | 175.89% |
| 2015 FY | 1.18 Million CAD | 157.0% |
| 2014 Q1 | 109.06 Thousand CAD | -11.06% |
| 2014 Q2 | 109.29 Thousand CAD | 0.21% |
| 2014 Q3 | 95.03 Thousand CAD | -13.05% |
| 2014 Q4 | 148.12 Thousand CAD | 55.87% |
| 2014 FY | 461.51 Thousand CAD | -20.47% |
| 2013 FY | 580.32 Thousand CAD | 0.0% |
| 2013 Q4 | 122.62 Thousand CAD | -0.52% |
| 2013 Q3 | 123.26 Thousand CAD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|